877
Views
63
CrossRef citations to date
0
Altmetric
Original Article: Clinical

A combination of rituximab, cyclophosphamide and dexamethasone effectively treats immune cytopenias of chronic lymphocytic leukemia

, , , , , , , & show all
Pages 892-899 | Received 21 Oct 2008, Accepted 10 Mar 2009, Published online: 21 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Tim R. De Back, Arnon P. Kater & Sanne H. Tonino. (2018) Autoimmune cytopenias in chronic lymphocytic leukemia: a concise review and treatment recommendations. Expert Review of Hematology 11:8, pages 613-624.
Read now
Preetesh Jain & Susan O'Brien. (2013) Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia. Expert Opinion on Biological Therapy 13:2, pages 169-182.
Read now
Tadeusz Robak. (2012) Rituximab for chronic lymphocytic leukemia. Expert Opinion on Biological Therapy 12:4, pages 503-515.
Read now
Anne-Sophie Michallet, Julien Rossignol, Bruno Cazin & Loic Ysebaert. (2011) Rituximab–cyclophosphamide–dexamethasone combination in management of autoimmune cytopenias associated with chronic lymphocytic leukemia. Leukemia & Lymphoma 52:7, pages 1401-1403.
Read now
Matthew Kaufman & Kanti Rai. (2010) The challenge of treating complex autoimmune cytopenias in chronic lymphocytic leukemia. Leukemia & Lymphoma 51:4, pages 574-575.
Read now
Deborah A. Bowen, Timothy G. Call, Tait D. Shanafelt, Neil E. Kay, Susan M. Schwager, Megan S. Reinalda, Kari G. Rabe, Susan L. Slager & Clive S. Zent. (2010) Treatment of autoimmune cytopenia complicating progressive chronic lymphocytic leukemia/small lymphocytic lymphoma with rituximab, cyclophosphamide, vincristine, and prednisone. Leukemia & Lymphoma 51:4, pages 620-627.
Read now
Clive S. Zent & Tait Shanafelt. (2009) Management of autoimmune cytopenia complicating chronic lymphocytic leukemia. Leukemia & Lymphoma 50:6, pages 863-864.
Read now

Articles from other publishers (56)

Eugene Nikitin, Maria Kislova, Dmitry Morozov, Vera Belyakova, Anna Suvorova, Julia Sveshnikova, Galina Vyscub, Irina Matveeva, Maria Shirokova, Anna Shipaeva, Tatyana Klitochenko, Polina Makarovskaya, Elena Dmitrieva, Bella Biderman, Andrei Sudarikov, Tatyana Obukhova, Olga Samoilova, Kamil Kaplanov, Tatyana Konstantinova, Olga Mayorova, Irina Poddubnaya & Vadim Ptushkin. (2023) Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias. Leukemia 37:7, pages 1464-1473.
Crossref
Y. Zadro, P. Cougoul, J. Dion, G. Moulis, A. Lusque, J. Thomazeau, J. Zordan, M. Gauthier, L. Ysebaert & T. Comont. (2022) Traitement du PTI et de l’AHAI associés aux hémopathies lymphoïdes B indolentes : faut-il traiter le clone ?. La Revue de Médecine Interne 43, pages A405.
Crossref
Max J. Gordon & Alessandra Ferrajoli. (2022) Unusual complications in the management of chronic lymphocytic leukemia . American Journal of Hematology 97:S2.
Crossref
Dominika Écsiová, Pavel Vodárek, Petra Rozsívalová, Filip Vrbacký, Kateřina Hrochová, Petr Hoffmann, Pavel Žák, Lukáš Smolej & Martin Šimkovič. (2022) Severe secondary immune thrombocytopenia in a patient with chronic lymphocytic leukemia. Onkologie 16:3, pages 151-154.
Crossref
Edit Porpaczy & Ulrich Jäger. (2022) How I manage autoimmune cytopenias in patients with lymphoid cancer. Blood 139:10, pages 1479-1488.
Crossref
Nil Albiol & Carol Moreno. (2021) Autoimmune Cytopenia in CLL. The Cancer Journal 27:4, pages 286-296.
Crossref
Alessandro Noto, Ramona Cassin, Veronica Mattiello & Gianluigi Reda. (2021) The Role of Novel Agents in Treating CLL-Associated Autoimmune Hemolytic Anemia. Journal of Clinical Medicine 10:10, pages 2064.
Crossref
Wilma Barcellini & Bruno Fattizzo. (2021) How I treat warm autoimmune hemolytic anemia. Blood 137:10, pages 1283-1294.
Crossref
Sylwia Sulimiera Michalak. 2021. Encyclopedia of Gerontology and Population Aging. Encyclopedia of Gerontology and Population Aging 553 563 .
Irina Murakhovskaya. (2020) Rituximab Use in Warm and Cold Autoimmune Hemolytic Anemia. Journal of Clinical Medicine 9:12, pages 4034.
Crossref
Sylwia Sulimiera Michalak, Anna Olewicz-Gawlik, Joanna Rupa-Matysek, Edyta Wolny-Rokicka, Elżbieta Nowakowska & Lidia Gil. (2020) Autoimmune hemolytic anemia: current knowledge and perspectives. Immunity & Ageing 17:1.
Crossref
Rohitashva Agrawal, Reinhold Munker & Maxwell M. Krem. (2020) Use of obinutuzumab for refractory autoimmune thrombocytopenia secondary to CLL. eJHaem 1:1, pages 368-370.
Crossref
Ulrich Jäger, Wilma Barcellini, Catherine M. Broome, Morie A. Gertz, Anita Hill, Quentin A. Hill, Bernd Jilma, David J. Kuter, Marc Michel, Marco Montillo, Alexander Röth, Sacha S. Zeerleder & Sigbjørn Berentsen. (2020) Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting. Blood Reviews 41, pages 100648.
Crossref
Vitale, Montalbano, Salvetti, Boccellato, Griggio, Boccadoro & Coscia. (2020) Autoimmune Complications in Chronic Lymphocytic Leukemia in the Era of Targeted Drugs. Cancers 12:2, pages 282.
Crossref
Bruno Fattizzo & Wilma Barcellini. (2020) Autoimmune Cytopenias in Chronic Lymphocytic Leukemia: Focus on Molecular Aspects. Frontiers in Oncology 9.
Crossref
Caroline I. Piatek, Hillel Bocian, Sandra Algaze, Ilene C. Weitz, Casey O'Connell & Howard A. Liebman. (2020) A Retrospective Study of the Combination of Rituximab, Cyclophosphamide and Dexamethasone for the Treatment of Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia. Acta Haematologica 143:3, pages 244-249.
Crossref
Clive S. Zent. (2019) Diagnosis and management of complications of chronic lymphocytic leukemia/small lymphocytic lymphoma. Acta Haematologica Polonica 50:3, pages 91-97.
Crossref
Quentin A. Hill, Anita Hill & Sigbjørn Berentsen. (2019) Defining autoimmune hemolytic anemia: a systematic review of the terminology used for diagnosis and treatment. Blood Advances 3:12, pages 1897-1906.
Crossref
Ilene Weitz. 2019. Anemia in the Young and Old. Anemia in the Young and Old 137 145 .
Sylwia Sulimiera Michalak. 2019. Encyclopedia of Gerontology and Population Aging. Encyclopedia of Gerontology and Population Aging 1 10 .
Carol Moreno, Carolina Cuellar & Eva Puy Vicente. 2019. Chronic Lymphocytic Leukemia. Chronic Lymphocytic Leukemia 123 136 .
Joanna Klubo-Gwiezdzinska, Maria LangeElaine Cochran, Robert K. Semple, Cornelia GewertRebecca J. Brown & Phillip Gorden. (2018) Combined Immunosuppressive Therapy Induces Remission in Patients With Severe Type B Insulin Resistance: A Prospective Cohort Study. Diabetes Care 41:11, pages 2353-2360.
Crossref
Anna H. Schuh, Nilima Parry-Jones, Niamh Appleby, Adrian Bloor, Claire E. Dearden, Christopher Fegan, George Follows, Christopher P. Fox, Sunil Iyengar, Ben Kennedy, Helen McCarthy, Helen M. Parry, Piers Patten, Andrew R. Pettitt, Ingo Ringshausen, Renata Walewska & Peter Hillmen. (2018) Guideline for the treatment of chronic lymphocytic leukaemia. British Journal of Haematology 182:3, pages 344-359.
Crossref
David Ribes, Hélène E. L. Hachem, Lucie Oberic, François Vergez, Audrey Delas, Julie Belliere, Caroline Protin, Nassim Kamar, Inès Ferrandiz, Suzanne Tavitian, Camille Laurent, Antoine Huart, Dominique Chauveau, Loïc Ysebaert & Stanislas Faguer. (2018) Bendamustine plus rituximab for indolent B-cell lymphoma of renal significance. American Journal of Hematology 93:3, pages 356-362.
Crossref
Deepa Jeyakumar & Susan O’Brien. 2018. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood 117 134 .
Bindumadhav M. Marathe, Heba H. Mostafa, Peter Vogel, Philippe Noriel Q. Pascua, Jeremy C. Jones, Charles J. Russell, Richard J. Webby & Elena A. Govorkova. (2017) A pharmacologically immunosuppressed mouse model for assessing influenza B virus pathogenicity and oseltamivir treatment. Antiviral Research 148, pages 20-31.
Crossref
Ronald S. Go, Jeffrey L. Winters & Neil E. Kay. (2017) How I treat autoimmune hemolytic anemia. Blood 129:22, pages 2971-2979.
Crossref
Mazie Tsang & Sameer A. Parikh. (2017) A Concise Review of Autoimmune Cytopenias in Chronic Lymphocytic Leukemia. Current Hematologic Malignancy Reports 12:1, pages 29-38.
Crossref
Francesca Arruga & Silvia Deaglio. 2018. Mechanisms of Drug Resistance in Cancer Therapy. Mechanisms of Drug Resistance in Cancer Therapy 203 229 .
Heba H. Mostafa, Peter Vogel, Ashok Srinivasan & Charles J. Russell. (2016) Non-invasive Imaging of Sendai Virus Infection in Pharmacologically Immunocompromised Mice: NK and T Cells, but not Neutrophils, Promote Viral Clearance after Therapy with Cyclophosphamide and Dexamethasone. PLOS Pathogens 12:9, pages e1005875.
Crossref
Kerry A. Rogers & Jennifer A. Woyach. (2016) Secondary autoimmune cytopenias in chronic lymphocytic leukemia. Seminars in Oncology 43:2, pages 300-310.
Crossref
Maria Theresa Krauth & Klaus Lechner. 2016. Nonmalignant Hematology. Nonmalignant Hematology 137 152 .
Daan Dierickx, Alain Kentos & André Delannoy. (2015) The role of rituximab in adults with warm antibody autoimmune hemolytic anemia. Blood 125:21, pages 3223-3229.
Crossref
Stephan StilgenbauerRichard R. FurmanClive S. Zent. (2015) Management of Chronic Lymphocytic Leukemia. American Society of Clinical Oncology Educational Book:35, pages 164-175.
Crossref
Anne Quinquenel, Christophe Willekens, Jehan Dupuis, Bruno Royer, Loic Ysebaert, S. De Guibert, Anne-Sophie Michallet, Pierre Feugier, Romain Guieze, Vincent Levy & Alain Delmer. (2015) Bendamustine and rituximab combination in the management of chronic lymphocytic leukemia-associated autoimmune hemolytic anemia: A multicentric retrospective study of the French CLL intergroup (GCFLLC/MW and GOELAMS). American Journal of Hematology 90:3, pages 204-207.
Crossref
Anne Quinquenel, Chadi Al Nawakil, Fanny Baran-Marszak, Virginie Eclache, Remi Letestu, Mohammed Khalloufi, Marouane Boubaya, Christine Le Roy, Nadine Varin-Blank, Alain Delmer, Vincent Levy & Florence Ajchenbaum-Cymbalista. (2015) Old DAT and new data: Positive direct antiglobulin test identifies a subgroup with poor outcome among chronic lymphocytic leukemia stage A patients. American Journal of Hematology 90:1, pages E5-E8.
Crossref
Petra Langerbeins, Raymonde Busch, Nadine Anheier, Jan Dürig, Manuela Bergmann, Maria-Elisabeth Goebeler, Hans-Jürgen Hurtz, Martina B. Stauch, Stephan Stilgenbauer, Hartmut Döhner, Anna-Maria Fink, Paula Cramer, Kirsten Fischer, Clemens-Martin Wendtner, Michael Hallek & Barbara Eichhorst. (2014) Poor efficacy and tolerability of R-CHOP in relapsed/refractory chronic lymphocytic leukemia and Richter transformation. American Journal of Hematology 89:12, pages E239-E243.
Crossref
Carlo Visco, Wilma Barcellini, Francesco Maura, Antonino Neri, Agostino Cortelezzi & Francesco Rodeghiero. (2014) Autoimmune cytopenias in chronic lymphocytic leukemia. American Journal of Hematology 89:11, pages 1055-1062.
Crossref
Marielle Perry, Antoine Delarche, David Ribes, François Vergez, Céline Guilbeau-Frugier, Camille Laurent, Antoine Huart, Suzanne Tavitian, Hélène El Hachem, Lucie Oberic, Dominique Chauveau, Anne-Sophie Michallet, Loïc Ysebaert & Stanislas Faguer. (2014) Rituximab-cyclophosphamide-dexamethasone is highly effective in patients with monoclonal Ig deposit-related glomerulopathy and indolent non-Hodgkin lymphomas. American Journal of Hematology 89:10, pages 969-973.
Crossref
Tadeusz Robak, Iwona Hus, Jerzy Błoński, Krzysztof Giannopoulos, Krzysztof Jamroziak, Jacek Roliński, Piotr Smolewski & Dariusz Wołowiec. (2014) Rekomendacje diagnostyczne i terapeutyczne dla przewlekłej białaczki limfocytowej w 2014 r. – raport Grupy Roboczej PTHiT oraz PALG – CLL. Acta Haematologica Polonica 45:3, pages 221-239.
Crossref
Kirsty Cuthill & Stephen Devereux. (2013) How I treat patients with relapsed chronic lymphocytic leukaemia. British Journal of Haematology 163:4, pages 423-435.
Crossref
José Carlos Jaime-Pérez, Marisol Rodríguez-Martínez, Andrés Gómez-de-León, Luz Tarín-Arzaga & David Gómez-Almaguer. (2013) Current Approaches for the Treatment of Autoimmune Hemolytic Anemia. Archivum Immunologiae et Therapiae Experimentalis 61:5, pages 385-395.
Crossref
Dariusz Wołowiec. (2013) Powikłania infekcyjne i autoimmunologiczne w przewlekłej białaczce limfocytowej. Acta Haematologica Polonica 44:3, pages 188-195.
Crossref
Gautam Borthakur & Susan O’Brien. 2013. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood 103 119 .
David Oscier, Claire Dearden, Efrem Eren, Christopher Fegan, George Follows, Peter Hillmen, Tim Illidge, Estella Matutes, Don W. Milligan, Andrew Pettitt, Anna Schuh & Jennifer Wimperis. (2012) Guidelines on the diagnosis, investigation and management of chronic lymphocytic leukaemia. British Journal of Haematology 159:5, pages 541-564.
Crossref
Daan Dierickx, Emilie Beke, Timothy Devos & André Delannoy. (2012) The Use of Monoclonal Antibodies in Immune-Mediated Hematologic Disorders. Medical Clinics of North America 96:3, pages 583-619.
Crossref
Tadeusz Robak. (2012) Przeciwciała monoklonalne w leczeniu przewlekłej białaczki limfocytowej. Acta Haematologica Polonica 43:2, pages 99-106.
Crossref
Chadi Al-Nawakil, Sophie Park, Nicolas Chapuis, Francois Dreyfus, Tali-Anne Szwebel, Laure Gibault, Thierry Molina, Olivier Hermine, Didier Bouscary & Jerome Tamburini. (2012) Salvage therapy of Autoimmune Thrombocytopenic Purpura revealing non-Hodgkin Lymphoma by the thrombopoietin receptor agonist romiplostim. British Journal of Haematology 156:1, pages 145-147.
Crossref
Paolo Strati & Federico Caligaris-Cappio. (2011) A matter of debate in chronic lymphocytic leukemia. Current Opinion in Oncology 23:5, pages 455-460.
Crossref
Kate Hodgson, Gerardo Ferrer, Arturo Pereira, Carol Moreno & Emili Montserrat. (2011) Autoimmune cytopenia in chronic lymphocytic leukaemia: diagnosis and treatment. British Journal of Haematology 154:1, pages 14-22.
Crossref
J Rossignol, A-S Michallet, L Oberic, M Picard, A Garon, C Willekens, R Dulery, X Leleu, B Cazin & L Ysebaert. (2010) Rituximab–cyclophosphamide–dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia. Leukemia 25:3, pages 473-478.
Crossref
Daan Dierickx, André Delannoy, Khalid Saja, Gregor Verhoef & Drew Provan. (2011) Anti-CD20 monoclonal antibodies and their use in adult autoimmune hematological disorders. American Journal of Hematology 86:3, pages 278-291.
Crossref
Klaus Lechner & Ulrich Jäger. (2010) How I treat autoimmune hemolytic anemias in adults. Blood 116:11, pages 1831-1838.
Crossref
Kumi Nakazaki, Akira Hangaishi, Fumihiko Nakamura, Masataka Hosoi, Yoichi Imai, Tsuyoshi Takahashi, Yasuhito Nannya & Mineo Kurokawa. (2010) IgG-associated immune thrombocytopenia in Waldenström macroglobulinemia. International Journal of Hematology 92:2, pages 360-363.
Crossref
Ulrich Jäger. (2010) Autoimmunhämolytische Anämie bei soliden Tumoren: Ein unterdiagnostiziertes Phänomen?. Wiener klinische Wochenschrift 122:7-8, pages 192-193.
Crossref
Clive S. Zent & Neil E. Kay. (2010) Autoimmune Complications in Chronic Lymphocytic Leukaemia (CLL). Best Practice & Research Clinical Haematology 23:1, pages 47-59.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.